BIO-TECHNE Corp Quarterly Other Liabilities, Noncurrent in USD from Q2 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
BIO-TECHNE Corp quarterly Other Liabilities, Noncurrent history and growth rate from Q2 2014 to Q3 2024.
  • BIO-TECHNE Corp Other Liabilities, Noncurrent for the quarter ending September 30, 2024 was $19.8M, a 111% increase year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $19.8M +$10.4M +111% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $13.2M +$2.24M +20.5% Jun 30, 2024 10-Q 2024-11-05
Q1 2024 $11.6M +$584K +5.32% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $17.4M +$6.03M +53.1% Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $9.39M -$2.11M -18.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $10.9M -$1.32M -10.8% Jun 30, 2023 10-K 2024-08-22
Q1 2023 $11M -$1.8M -14.1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $11.3M -$411K -3.5% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $11.5M -$8.55M -42.6% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $12.2M -$12.2M -50% Jun 30, 2022 10-K 2023-08-23
Q1 2022 $12.8M -$11M -46.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $11.7M -$14M -54.5% Dec 31, 2021 10-Q 2022-02-07
Q3 2021 $20M -$9.94M -33.1% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $24.5M -$2.49M -9.23% Jun 30, 2021 10-K 2022-08-24
Q1 2021 $23.8M -$4.24M -15.1% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $25.8M +$5.09M +24.6% Dec 31, 2020 10-Q 2021-02-08
Q3 2020 $30M +$7.53M +33.5% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $26.9M +$1.73M +6.85% Jun 30, 2020 10-K 2021-08-25
Q1 2020 $28.1M +$8.56M +43.9% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $20.7M +$2.71M +15.1% Dec 31, 2019 10-Q 2020-02-06
Q3 2019 $22.5M +$12.8M +132% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $25.2M +$15.9M +170% Jun 30, 2019 10-K 2020-08-26
Q1 2019 $19.5M +$10.4M +113% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $18M +$8.67M +93% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 $9.67M +$3.42M +54.6% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $9.34M +$3.94M +72.8% Jun 30, 2018 10-K/A 2019-11-06
Q1 2018 $9.14M +$4.74M +108% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $9.32M +$5.69M +157% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 $6.26M +$2.6M +71.2% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $5.4M +$2.09M +62.9% Jun 30, 2017 10-K 2018-08-27
Q1 2017 $4.4M +$1.23M +39% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $3.63M +$408K +12.7% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $3.65M +$508K +16.1% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $3.32M +$113K +3.53% Jun 30, 2016 10-K 2017-09-07
Q1 2016 $3.16M +$1.02M +47.6% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $3.22M +$1.32M +69.8% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $3.15M +$2.44M +344% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $3.2M +$3.2M Jun 30, 2015 10-K 2016-08-29
Q1 2015 $2.14M Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $1.9M Dec 31, 2014 10-Q 2015-02-09
Q3 2014 $708K Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $0 Jun 30, 2014 10-K 2015-08-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.